Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Black mamba venom peptides target acid-sensing ion channels to abolish painNature (London), 2012-10, Vol.490 (7421), p.552-555 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Oct 25, 2012 ;Attribution ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature11494 ;PMID: 23034652 ;CODEN: NATUASFull text available |
|
2 |
Material Type: Article
|
Reply on new drugs against type 2 diabetes: important to gain experience and knowledgeLäkartidningen, 2008-04, Vol.105 (17-18), p.1310, 1312 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 18561535Full text available |
|
3 |
Material Type: Article
|
Socker triggar våra belöningssystem. Sött frisätter opiater som sätter fart på sötsuget - insulin kan dämpa detLäkartidningen, 2005-05, Vol.102 (21), p.1620 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518Full text available |
|
4 |
Material Type: Article
|
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical TrialDiabetes care, 2018-02, Vol.41 (2), p.258-266 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-0417 ;PMID: 29246950Full text available |
|
5 |
Material Type: Article
|
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)Diabetes care, 2014-08, Vol.37 (8), p.2159-2167 [Peer Reviewed Journal]2015 INIST-CNRS ;2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 2014 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-2760 ;PMID: 24879836 ;CODEN: DICAD2Full text available |
|
6 |
Material Type: Article
|
Tirzepatide Once Weekly for the Treatment of ObesityThe New England journal of medicine, 2022-07, Vol.387 (3), p.205-216 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206038 ;PMID: 35658024Full text available |
|
7 |
Material Type: Article
|
Once-Weekly Semaglutide in Adults with Overweight or ObesityThe New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2032183 ;PMID: 33567185Full text available |
|
8 |
Material Type: Article
|
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisThe New England journal of medicine, 2021-03, Vol.384 (12), p.1113-1124 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2028395 ;PMID: 33185364Full text available |
|
9 |
Material Type: Article
|
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2017-10, Vol.390 (10103), p.1664-1675 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 7, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31585-4 ;PMID: 28781108Full text available |
|
10 |
Material Type: Article
|
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesThe New England journal of medicine, 2021-08, Vol.385 (6), p.503-515 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107519 ;PMID: 34170647Full text available |
|
11 |
Material Type: Article
|
Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease modelNature neuroscience, 2019-05, Vol.22 (5), p.719-728 [Peer Reviewed Journal]2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 ;ISSN: 1097-6256 ;EISSN: 1546-1726 ;DOI: 10.1038/s41593-019-0372-9 ;PMID: 30936558Full text available |
|
12 |
Material Type: Article
|
Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissuesAdvanced drug delivery reviews, 2016-11, Vol.106, p.256 [Peer Reviewed Journal]ISSN: 1872-8294 ;ISSN: 0169-409X ;EISSN: 1872-8294 ;DOI: 10.1016/j.addr.2016.07.007Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesThe New England journal of medicine, 2019-08, Vol.381 (9), p.841-851 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901118 ;PMID: 31185157Full text available |
|
14 |
Material Type: Article
|
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trialThe Lancet (British edition), 2019-07, Vol.394 (10192), p.39-50 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31271-1 ;PMID: 31186120Full text available |
|
15 |
Material Type: Article
|
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesThe New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1612917 ;PMID: 28910237Full text available |
|
16 |
Material Type: Article
|
Cationic Cell-Penetrating Peptides Are Potent Furin InhibitorsPloS one, 2015-06, Vol.10 (6), p.e0130417-e0130417 [Peer Reviewed Journal]2015 Ramos-Molina et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Ramos-Molina et al 2015 Ramos-Molina et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0130417 ;PMID: 26110264Full text available |
|
17 |
Material Type: Article
|
Early versus Delayed, Provisional Eptifibatide in Acute Coronary SyndromesThe New England journal of medicine, 2009-05, Vol.360 (21), p.2176-2190 [Peer Reviewed Journal]Copyright © 2009 Massachusetts Medical Society. All rights reserved. ;2009 INIST-CNRS ;2009 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0901316 ;PMID: 19332455 ;CODEN: NEJMAGFull text available |
|
18 |
Material Type: Article
|
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 DiabetesDiabetes care, 2019-09, Vol.42 (9), p.1724-1732 [Peer Reviewed Journal]2019 by the American Diabetes Association. ;Copyright American Diabetes Association Sep 1, 2019 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-0749 ;PMID: 31186300Full text available |
|
19 |
Material Type: Article
|
Effects of Doxorubicin on the Liquid-Liquid Phase Change Properties of Elastin-Like PolypeptidesBiophysical journal, 2018-10, Vol.115 (8), p.1431-1444 [Peer Reviewed Journal]2018 Biophysical Society ;Copyright © 2018 Biophysical Society. Published by Elsevier Inc. All rights reserved. ;2018 Biophysical Society. 2018 Biophysical Society ;ISSN: 0006-3495 ;EISSN: 1542-0086 ;DOI: 10.1016/j.bpj.2018.09.006 ;PMID: 30292393Full text available |
|
20 |
Material Type: Article
|
Designing antimicrobial peptides: form follows functionNature reviews. Drug discovery, 2012-01, Vol.11 (1), p.37-51 [Peer Reviewed Journal]COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2012 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd3591 ;PMID: 22173434Full text available |